300239.SZ · 东宝生物
China A-shares · RS rating 82 · As of 2026-10-14
| Price | 5.24 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 83 / 62 / 66 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 41 / 17 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +17.7% |
| Distance from 52-week high | +21.0% |
| Market cap (USD) | $491.8M |